TA
ABBV icon

Trellis Advisors’s AbbVie ABBV Stock Holding History

Trellis Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,852
Closed -$425K – 2
2023
Q3 		$425K Buy
2,852
+20
+0.7% +$2.94K 0.19% 49
2023
Q2 		$382K Sell
2,832
-23
-0.8% -$3.37K 0.17% 52
2023
Q1 		$455K Buy
2,855
+24
+0.8% +$3.67K 0.22% 48
2022
Q4 		$458K Sell
2,831
-100
-3% -$15.3K 0.24% 43
2022
Q3 		$394K Buy
2,931
+61
+2% +$8.75K 0.22% 46
2022
Q2 		$439K Buy
2,870
+81
+3% +$12.4K 0.24% 44
2022
Q1 		$452K Sell
2,789
-20
-0.7% -$2.9K 0.23% 45
2021
Q4 		$380K Sell
2,809
-36
-1% -$4.25K 0.18% 54
2021
Q3 		$307K Buy
2,845
+25
+0.9% +$2.86K 0.16% 58
2021
Q2 		$318K Sell
2,820
-6
-0.2% -$676 0.17% 57
2021
Q1 		$306K Buy
2,826
+417
+17% +$44.6K 0.17% 54
2020
Q4 		$258K Buy
+2,409
New +$231K 0.16% 64
2020
Q3 		– Sell
-2,242
Closed -$220K – 69
2020
Q2 		$220K Buy
+2,242
New +$197K 0.17% 55
2018
Q1 		– Sell
-2,161
Closed -$209K – 44
2017
Q4 		$209K Buy
+2,161
New +$204K 0.2% 40

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Trellis Advisors's ABBV Position: Q4 2023 in Review

Trellis Advisors sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 2,852 shares — an estimated $425K sold.

Trellis Advisors first reported a position in ABBV in Q4 2017 and held it in 14 quarters. The position peaked at $458K in Q4 2022. 3,323 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • Trellis Advisors reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
  • Trellis Advisors sold 2,852 AbbVie shares in Q4 2023, an estimated $425K.
  • Trellis Advisors first reported a position in AbbVie in Q4 2017 and held it in 14 quarters.
  • Trellis Advisors's AbbVie position peaked at $458K in Q4 2022.
  • 3,323 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Trellis Advisors's 13F filing for Q4 2023.